Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
Eli Lilly and Company
Eli Lilly and Company
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Emory University
Bio-Path Holdings, Inc.
Nkarta, Inc.